You are here

Article info

Article menu

Download PDFPDF

Review
Prospects for combined use of oncolytic viruses and CAR T-cells

Authors

  • Adam Ajina Department of OncologyRoyal Free London NHS Foundation Trust London UK PubMed articlesGoogle scholar articles
  • John Maher King’s College London, CAR Mechanics Group, School of Cancer and Pharmaceutical Sciences, Guy’s Hospital Campus Great Maze Pond SE1 9RT London UK Department of Clinical Immunology and AllergyKing’s College Hospital NHS Foundation Trust London UK Department of ImmunologyEastbourne Hospital East Sussex UK PubMed articlesGoogle scholar articles

Citation

Ajina A, Maher J
Prospects for combined use of oncolytic viruses and CAR T-cells
Journal for ImmunoTherapy of Cancer 2017;5:90. doi: 10.1186/s40425-017-0294-6
Online issue publication 
February 09, 2021

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© The Author(s). Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.